INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 263 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $203,570 | -7.6% | 6,438 | +20.3% | 0.00% | -33.3% |
| Q2 2023 | $220,355 | +6.9% | 5,352 | -3.3% | 0.00% | 0.0% |
| Q1 2023 | $206,216 | -94.1% | 5,533 | -52.4% | 0.00% | -90.0% |
| Q4 2022 | $3,520,570 | +438.0% | 11,628 | -0.7% | 0.03% | +400.0% |
| Q3 2022 | $654,422 | +112.1% | 11,712 | +96.5% | 0.01% | -14.3% |
| Q2 2022 | $308,490 | +13.0% | 5,960 | +58.9% | 0.01% | +16.7% |
| Q1 2022 | $273,000 | -38.7% | 3,751 | -0.5% | 0.01% | -45.5% |
| Q4 2021 | $445,000 | -12.6% | 3,769 | -0.8% | 0.01% | -26.7% |
| Q3 2021 | $509,000 | -17.0% | 3,800 | +0.4% | 0.02% | -16.7% |
| Q2 2021 | $613,000 | +49.5% | 3,783 | -25.9% | 0.02% | +28.6% |
| Q1 2021 | $410,000 | +314.1% | 5,105 | +181.4% | 0.01% | +250.0% |
| Q4 2020 | $99,000 | +175.0% | 1,814 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $36,000 | -5.3% | 1,814 | 0.0% | 0.00% | -20.0% |
| Q2 2020 | $38,000 | +72.7% | 1,814 | 0.0% | 0.01% | +66.7% |
| Q1 2020 | $22,000 | -91.7% | 1,814 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $266,000 | +1008.3% | 1,814 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $24,000 | -20.0% | 1,814 | 0.0% | 0.00% | -25.0% |
| Q2 2019 | $30,000 | -3.2% | 1,814 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $31,000 | +24.0% | 1,814 | 0.0% | 0.00% | -42.9% |
| Q4 2018 | $25,000 | -51.9% | 1,814 | 0.0% | 0.01% | -56.2% |
| Q3 2018 | $52,000 | +36.8% | 1,814 | 0.0% | 0.02% | -23.8% |
| Q1 2018 | $38,000 | +8.6% | 1,814 | 0.0% | 0.02% | +10.5% |
| Q4 2017 | $35,000 | +20.7% | 1,814 | 0.0% | 0.02% | +58.3% |
| Q2 2017 | $29,000 | +11.5% | 1,814 | 0.0% | 0.01% | -14.3% |
| Q1 2017 | $26,000 | -16.1% | 1,814 | 0.0% | 0.01% | -56.2% |
| Q3 2016 | $31,000 | -20.5% | 1,814 | 0.0% | 0.03% | -13.5% |
| Q2 2016 | $39,000 | – | 1,814 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 572,950 | $19,990,226 | 5.79% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $39,952,225 | 5.34% |
| MPM BioImpact LLC | 455,238 | $15,883,254 | 4.12% |
| ARK Investment Management | 9,420,782 | $328,691,084 | 2.85% |
| Atlas Venture Associates IX, LLC | 10,000 | $348,900 | 1.74% |
| Ghisallo Capital Management LLC | 250,000 | $8,722,500 | 1.55% |
| Nikko Asset Management Americas, Inc. | 2,976,002 | $103,743,430 | 1.49% |
| Prosight Management, LP | 72,116 | $2,516,127 | 1.37% |
| Rokos Capital Management LLP | 826,063 | $28,391,785 | 1.24% |
| Elmwood Wealth Management, Inc. | 67,899 | $2,368,996 | 1.18% |